Industry research
Orthopaedic devices
Scope
Europe
Companies
86
Table of contents
Report collaborator:
Sébastien Caron, Director at CIL Strategy Consultants, provided expert insights for this report. He covers CIL’s Healthcare & Life Sciences practice as sector specialist.
Key takeaways
What is the scope of this industry report?
The European orthopaedic devices market comprises businesses that develop, manufacture and distribute products for the surgical and non-surgical treatment of the musculoskeletal system. Based on the product characteristics and applications, we segmented the market into
orthopaedic implants
prosthetics and orthotics
instruments and materials.
What does the Orthopaedic devices landscape look like in Europe?
The orthopaedic devices market exhibits a high degree of consolidation across implants, prosthetics and orthotics. Herein, the global market is dominated by Zimmer Biomet (US), Stryker (US), J&J MedTech (US), and Smith & Nephew for implants, and by Ottobock and Embla Medical for prosthetics and orthotics. Across these segments, further consolidation is expected in Europe, as scale is necessary to both place successful product platforms in the market and to cope with ever-stricter EU regulation, which is driving up costs and disproportionately affecting smaller incumbents. On the other hand, the instruments and materials segment is rather fragmented and is characterised by leading European players that constantly capitalise on changing surgical trends to offer premium products, thereby achieving solid profitability margins.
What does the Orthopaedic devices market landscape look like in Europe?
Sponsor-led interest has been significant, with ~57% of identified assets being backed by financial sponsors (as of June 2026). This interest is mainly driven by (i) structural long-term demand across the European population, fuelled by an ageing demographic and obesity trends, (ii) international expansion potential across emerging economies in need of orthopaedic implants and prosthetics and (iii) top-line and profitability opportunities originating in the digitalisation of orthopaedic procedures (e.g. robot-assisted surgery techniques). On the other hand, (i) surgery capacity constraints across the European healthcare industry, (ii) a tightening regulatory environment and (iii) growing price pressures fostered by EU healthcare spending cuts and the professionalisation of hospital procurement departments serve as detractors for investors.
What are the key ESG considerations in the European Orthopaedic devices industry?
ESG topics primarily relate to environmental and social issues. On the environmental front, players increasingly adopt sustainable operational practices to achieve a circular value chain. Herein, incumbents modify their packaging, switch to sustainable energy to reduce their carbon footprint and incorporate 3D printing and manufacturing to reduce resource inputs and production-related waste. From a social perspective, the main challenge is ensuring the availability of products that improve the lives of people with disabilities. Herein, players work in tandem with public organisations to ensure the affordability of orthopaedic devices. Additionally, industry incumbents focus on individual well-being by promoting patient-friendly product development processes, such as aligning new products with minimally invasive surgery trends.
Company benchmarking
Market growth
The global markets for (i) bracing & supports, (ii) prosthetics and (iii) neuro orthotics were valued at ~$3.0bn, ~$2.0bn and ~$0.5bn in 2025, respectively, with estimated median annual growth rates of ~2.5%, ~7.0% and ~11.0% in the mid-to-long term (Embla Medical, April 2026)
The European orthopaedic devices market reached ~€13.4bn in size in 2025 and is projected to grow to ~€17.1bn by 2030 (+5% CAGR 2025-2030). This is confirmed by an industry expert who expects the market to grow at mid-single-digit rates over the next 5–10 years (CIL expert interview; Statista, January 2026)
Positive drivers
Ageing demographics and rising obesity rates drive demand for orthopaedic devices, with individuals aged 65+ projected to account for ~30% of Europe's population by 2050 and about half of Europeans expected to be overweight by 2030. As a result, the prevalence of musculoskeletal conditions is expected to continue its increase (CIL expert interview; Eurostat, February 2026; Nature, September 2025; The Lancet Healthy Longevity, May 2025; Eufic, October 2024)
Expansion into underpenetrated emerging markets offers significant growth potential, with these regions accounting for >80% of amputee volumes (~25m vs ~5m in developed markets). Herein, growing middle classes, limited healthcare infrastructure, and rising conflict-related O&P care needs (e.g. the Ukraine war, Middle East conflicts) are expected to increase demand, thereby stimulating growth for identified players (Ottobock, June 2026; Embla Medical, April 2026)
Digitalisation of orthopaedic procedures, including robotics and AI-assisted surgery, reshapes instrument design, promoting customisation and surgical workflows. Herein, niche-like and less commoditised, differentiated segments (e.g. spine and sports medicine orthopaedics) are expected to offer more opportunities for premium positioning and drive top-line growth and profitability (CIL expert interview)
Negative drivers
Healthcare system capacity constraints across Europe limit surgery volumes despite resilient underlying demand, with elective orthopaedic procedures (e.g. hip and knee replacements) still affected by waiting lists throughout the whole region (CIL expert interview; OECD, November 2024)
Tightening European MDR and EUDAMED requirements have intensified certification, clinical evidence, post-market surveillance and unique device identification ("UDI") registration burdens, disproportionately squeezing profitability and growth prospects for smaller manufacturers (CIL expert interview; CMS Law, May 2026)
Professionalisation of hospital procurement departments as well as EU cuts in healthcare spending are expected to increase price pressures on orthopaedic device manufacturers, particularly across products involving mature, standardised and most common surgical categories such as hip and knee implants (CIL expert interview; Vital Signs, March 2026; Le Monde, July 2025)
Fill out the form to request your copy of the Orthopaedic devices industry report
With the full report, you’ll gain access to:
Detailed assessments of the market outlook
Insights from c-suite industry executives
A clear overview of all active investors in the industry
An in-depth look into 86 private companies, incl. financials, ownership details and more.
A view on all 321 deals in the industry
ESG assessments with highlighted ESG outperformers
Discover hundreds of niche industry reports on Gain
Deep dive into additional industries to understand their market outlook, positive and negative drivers, and more!
